Dr. Lisa A. Ferrara, MD

Dr. Ferrara practices at Bon Secours Charity Health System Medical Group in Warwick, New York.

Dr. Ferrara's NPI, 1861563736, was assigned on November 13, 2006. Dr. Ferrara graduated from Rutgers Robert Wood Johnson Medical School in 1990. Dr. Ferrara holds New York license 192732.

Dr. Ferrara's primary practice is Bon Secours Charity Health System Medical Group, at 20 Grand St, Warwick, NY 10990 in Orange County. The practice phone is (845) 987-3906.

Dr. Ferrara's primary practice is Bon Secours Charity Health System Medical Group in Warwick, New York. Dr. Ferrara is also affiliated with Englewood Hospital. The medical group on file is Bon Secours Medical Group. Dmand AI also links Dr. Ferrara to 3 more hospitals, 3 home health agencies, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ferrara practices, 9 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Ferrara's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Ferrara's licenses on file in 2 states: New York and New Jersey.

CMS data shows 2,157 Medicare services from Dr. Ferrara across 17 procedure codes in 2024, for 602 Medicare patients. Medicare paid $209,066 for them. Every service was in an office.

CMS counts 602 Medicare patients who saw Dr. Ferrara in 2024. The largest group is 75 to 84, with 260 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ferrara's median patient age at 68, with 75% women.

In 2024, Dr. Ferrara wrote 4,665 Medicare Part D claims for 652 patients. 93% of them were for generic drugs. CMS names the drug for 4,132 of them, across 82 drugs with 11 or more claims each, at $169,409 in total drug cost. In 2023, CMS named 4,046 claims across 86 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Ferrara for performance year 2024, reported through an alternative payment model (APM). Dr. Ferrara accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ferrara as offering telehealth.

Dmand AI links 20 papers to Dr. Ferrara, published from 2011 to 2025. 2020 was the busiest year, with 6. The most frequent topics are Biomechanical Phenomena, Lumbar Vertebrae and Spinal Fusion. Dr. Ferrara has published most often in Int J Spine Surg. Dr. Ferrara's most frequent co-authors are Domagoj Coric, MD, Rohit Kumar Khanna, MD and Kaiuwe Lewandrowski, MD.

CMS Open Payments shows 200 general payments to Dr. Ferrara from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $1,331.

Dr. Ferrara graduated from Rutgers Robert Wood Johnson Medical School in 1990.